for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Agilent Technologies Inc

A.N

Latest Trade

78.45USD

Change

0.38(+0.49%)

Volume

338,815

Today's Range

78.07

 - 

78.63

52 Week Range

61.01

 - 

82.26

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
78.07
Open
78.22
Volume
338,815
3M AVG Volume
54.59
Today's High
78.63
Today's Low
78.07
52 Week High
82.26
52 Week Low
61.01
Shares Out (MIL)
309.47
Market Cap (MIL)
24,005.41
Forward P/E
25.15
Dividend (Yield %)
0.85

Next Event

Dividend For A.N - 0.1640 USD

Latest Developments

More

Agilent Technologies Announces Pricing Of $500 Million Of Senior Notes

Agilent Technologies Announces Proposed Offering Of Senior Notes

Agilent Technologies Says Q3 GAAP Earnings Per Share $0.60

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Agilent Technologies Inc

Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business. Its life sciences and applied markets business segment offers instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. Its diagnostics and genomics business segment includes the reagent partnership, pathology, companion diagnostics, genomics and the nucleic acid solutions businesses. Its Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio.

Industry

Scientific & Technical Instr.

Contact Info

5301 Stevens Creek Blvd

+1.408.3458886

https://www.agilent.com/

Executive Leadership

Boon Hwee Koh

Independent Chairman of the Board

Michael R. McMullen

President, Chief Executive Officer, Director

Robert W. McMahon

Chief Financial Officer, Senior Vice President

Michael Tang

Senior Vice President, General Counsel, Secretary

Dominique P. Grau

Senior Vice President - Human Resources

Key Stats

2.00 mean rating - 14 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

4.2K

2017

4.5K

2018

4.9K

2019(E)

5.1K
EPS (USD)

2016

1.980

2017

2.360

2018

2.790

2019(E)

3.084
Price To Earnings (TTM)
22.81
Price To Sales (TTM)
4.72
Price To Book (MRQ)
5.07
Price To Cash Flow (TTM)
18.34
Total Debt To Equity (MRQ)
37.88
LT Debt To Equity (MRQ)
27.26
Return on Investment (TTM)
15.22
Return on Equity (TTM)
12.85

Latest News

BRIEF-Agilent signs agreement to acquire assets from Young In Scientific

* AGILENT SIGNS AGREEMENT TO ACQUIRE ASSETS FROM YOUNG IN SCIENTIFIC CO. LTD.

BRIEF-Agilent Technologies To Acquire Privately-Held Genohm

* AGILENT TECHNOLOGIES TO ENHANCE LAB INFORMATICS WITH ACQUISITION OF GENOHM

BRIEF-Agilent Technologies Files Civil Lawsuit Against Pannatek, Including Former Agilent Employee

* AGILENT TECHNOLOGIES INC - FILES CIVIL LAWSUIT AGAINST CHANGZHOU PANNATEK CO., INCLUDING FORMER AGILENT EMPLOYEE

BRIEF-Alnylam Pharma Co, Agilent Technologies Entered Manufacturing Services Agreement Providing For Supply Of Patisiran Drug Substance By Agilent

* CO, AGILENT TECHNOLOGIES ENTERED MANUFACTURING SERVICES AGREEMENT PROVIDING FOR SUPPLY OF PATISIRAN DRUG SUBSTANCE BY AGILENT

BRIEF-Agilent Technologies Agrees To Buy Lasergen For $105 Mln

* AGILENT TECHNOLOGIES SIGNS AGREEMENT TO ACQUIRE LASERGEN, INC.

BRIEF-Agilent Technologies To Acquire Advanced Analytical Technologies, Inc.

* AGILENT TECHNOLOGIES TO ACQUIRE ADVANCED ANALYTICAL TECHNOLOGIES, INC.

BRIEF-Agilent And Imperial College London Announce Collaboration Agreement

* AGILENT AND IMPERIAL COLLEGE LONDON ANNOUNCE COLLABORATION AGREEMENT

BRIEF-Agilent Technologies Q1 GAAP Loss Per Share $0.99

* AGILENT TECHNOLOGIES REPORTS FIRST-QUARTER FISCAL YEAR 2018 FINANCIAL RESULTS

BRIEF-Agilent Technologies CEO Michael Mcmullen's 2017 Total Compensation Was $10.1 Mln Vs $8.9 Mln In 2016

* AGILENT TECHNOLOGIES INC - CEO MICHAEL R. MCMULLEN'S 2017 TOTAL COMPENSATION WAS $10.1 MILLION VERSUS $8.9 MILLION IN 2016 - SEC FILING Source text (http://bit.ly/2BRfYYG) Further company coverage:

BRIEF-Agilent Technologies Board Increases Size From 11 To 12 Members

* AGILENT TECHNOLOGIES INC SAYS ON JANUARY 17, BOARD INCREASED ITS SIZE FROM 11 TO 12 MEMBERS -SEC FILING Source text: (http://bit.ly/2EVj4Zh) Further company coverage:

BRIEF-Agilent Expands Cell Analysis Portfolio With Acquisition Of Luxcel Biosciences

* AGILENT EXPANDS CELL ANALYSIS PORTFOLIO WITH ACQUISITION OF LUXCEL BIOSCIENCES

BRIEF-Agilent Technologies Q4 non-gaap earnings per share $0.67

* Agilent Technologies reports fourth-quarter fiscal year 2017 financial results

BRIEF-Agilent technologies increases cash dividend to 14.9 cents per share

* Agilent technologies increases cash dividend to 14.9 cents per share Source text for Eikon: Further company coverage:

BRIEF-Agilent Technologies receives expanded FDA approval for Dako PD-L1 IHC 22C3 pharmDx

* Agilent Technologies receives expanded FDA approval for the use of Dako PD-L1 IHC 22C3 pharmDx companion diagnostic in gastric or gastroesophageal junction (GEJ) cancer Source text for Eikon: Further company coverage:

BRIEF-Agilent Technologies announces sponsorship deal with LabCentral

* Announced platinum sponsorship agreement with LabCentral, co to equip LabCentral's shared laboratory workspace with co's technology

BRIEF-Agilent announces expanded use of cancer diagnostic in U.S.

* Says FDA approved cancer diagnostic for use in cases of UC and of Squamous Cell Carcinoma of head & neck Source text for Eikon: Further company coverage:

BRIEF-AGILENT OBTAINS U.S. FDA APPROVAL FOR GENETISURE DX POSTNATAL ASSAY

* AGILENT OBTAINS U.S. FDA APPROVAL FOR GENETISURE DX POSTNATAL ASSAY

BRIEF-Agilent Technologies files lawsuit against Shanghai Echrom Electronic and former employees

* FILED A CIVIL LAWSUIT AGAINST SHANGHAI ECHROM ELECTRONIC TECHNOLOGY CO LTD AND SEVERAL FORMER EMPLOYEES OF AGILENT

BRIEF-Agilent Technologies reports Q3 non-GAAP earnings per share of $0.59

* Agilent Technologies reports third-quarter fiscal year 2017 financial results

BRIEF-Agilent acquires Next Generation Sequencing IP portfolio

* Agilent acquires powerful Next Generation Sequencing IP portfolio

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up